69656-101 : Varubi 90 mg Oral Tablet


NDC: 69656-101
Labeler: Tesaro, Inc.
Product Type: Human Prescription Drug
Drug Name:  Varubi
Dosage Form: Oral Tablet
Application #: NDA206500
Rev. Date: 


Appearance:


Markings: T0101;100
Shapes:  Oval
Colors:  Blue
Size (mm): 15
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 69656-101-02: 2 TABLET IN 1 BLISTER PACK (69656‑101‑02)

Active Ingredients:

  • Rolapitant Hydrochloride

Dosage Strength:

  • 90 mg

Pharmaceutical Classes:

  • Neurokinin 1 Antagonists [MoA]
  • Substance P/Neurokinin-1 Receptor Antagonist [EPC]
  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Breast Cancer Resistance Protein Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 69656-102 Varubi 1.8 mg/ml Intravenous Injection, Emulsion by Tesaro, Inc.
  • 70720-101 Varubi 90 mg Oral Tablet by Tersera Therapeutics LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69656-101 QR Code

< Prev: 69654-584Next: 69656-102 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.